When Is a Autologous Bone Marrow Transplantation Indicated in the Treatment of Juvenile Systemic Sclerorsis? Results of a Multinational Survey of Pediatric Rheumatologist
Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-9-s1-p73
Full Text
Open PDFAbstract
Available in full text
Date
September 14, 2011
Authors
Publisher
Springer Science and Business Media LLC